Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Liang

Showing results (641-650 of 660) with videos related to

Pageof 66
Sort By:
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cell Systems|July 26, 2019
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' DataGalen F Gao, Joel S Parker, Sheila M Reynolds, et al.
Cancer Communications (London, England)|July 1, 2021
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021Feng-Hua Wang, Xiao-Tian Zhang, Yuan-Fang Li, et al.
Cancer Communications (London, England)|December 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, et al.
The Lancet. Oncology|July 12, 2021
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Nature Communications|December 10, 2015
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomasKui Wu, Xin Zhang, Fuqiang Li, et al.
The Lancet. Oncology|February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Cancer Cell|March 14, 2018
Systematic Functional Annotation of Somatic Mutations in CancerPatrick Kwok-Shing Ng, Jun Li, Kang Jin Jeong, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Cancer Cell|May 23, 2017
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsYiqun Zhang, Patrick Kwok-Shing Ng, Melanie Kucherlapati, et al.
Pageof 66

Showing results (641-650 of 660) with videos related to

Sort By:
Pageof 66
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cell Systems|July 26, 2019
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' DataGalen F Gao, Joel S Parker, Sheila M Reynolds, et al.
Cancer Communications (London, England)|July 1, 2021
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021Feng-Hua Wang, Xiao-Tian Zhang, Yuan-Fang Li, et al.
Cancer Communications (London, England)|December 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, et al.
The Lancet. Oncology|July 12, 2021
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Nature Communications|December 10, 2015
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomasKui Wu, Xin Zhang, Fuqiang Li, et al.
The Lancet. Oncology|February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Cancer Cell|March 14, 2018
Systematic Functional Annotation of Somatic Mutations in CancerPatrick Kwok-Shing Ng, Jun Li, Kang Jin Jeong, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Cancer Cell|May 23, 2017
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsYiqun Zhang, Patrick Kwok-Shing Ng, Melanie Kucherlapati, et al.
Pageof 66